Mar 05, 2020
Berkeley Lights Launches T Cell Receptor Sequencing Kit to Increase Efficiency of T Cell Receptor Discovery
Apr 04, 2019
Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia
Apr 01, 2019
TCR2 Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 28, 2019
TCR2 Therapeutics Presents Preclinical Data on its Lead Solid Tumor and Blood Cancer Programs at the American Association for Cancer Research (AACR) Annual Meeting
Mar 26, 2019
TCR2 Therapeutics Announces Collaboration With Cell and Gene Therapy Catapult for the Manufacturing of its Novel T Cell Therapies for Cancer
Mar 14, 2019
Targovax Grants Zelluna Immunotherapy an FTO License to Intellectual Property Relating to Mutant Ras T Cell Receptor Technology
Feb 01, 2019
TCR2 Therapeutics Launches Proposed Initial Public Offering
Nov 29, 2018
TCR2 Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards(TM) Life Sciences 2018 Event
Jul 23, 2018
GigaMune Secures Collaboration with Mass General for Development of Cell Therapies for Cancer
Jun 28, 2018
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Jun 14, 2018
2018 TCR-Based Antibody and T-Cell Immunotherapy Report Package: Two Full Reports Covering TCR-based T-cell and Recombinant Antibody (Fusion Protein) Immunotherapy of Cancer
Jun 06, 2018
TCR Engineered T-Cell Therapy Market Report 2018: Technologies, Pipeline, Manufacturing, Companies, Financing & Outlook
May 14, 2018
TCR2 Therapeutics to Present at the UBS Global Healthcare Conference and the Jefferies 2018 Global Healthcare Conference
May 01, 2018
AgenTus Therapeutics to Present on Novel TCR Platform and Progress at PEGS Summit in Boston, MA
Apr 10, 2018
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
Feb 05, 2018
TCR2 Therapeutics to Present at the 2018 Keystone Symposia Conference on Emerging Cellular Therapies: T Cells and Beyond
Feb 01, 2018
Global Intracellular Targets Made Druggable Market 2018: Industry Analysis of Technologies, Stakeholders, Deals & Trends - TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics
Jan 03, 2018
TCR2 Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 11, 2017
Medigene Collaborates with RXi Pharmaceuticals to Further Sharpen its Therapeutic T cells
Nov 02, 2017
TCR2 Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board